Phenotype Identification Will Open Door to Precision Medicine
Researchers have developed a low-cost, AI-driven method using label-free optical microscopy to identify cancer phenotypes.
Researchers have developed a low-cost, AI-driven method using label-free optical microscopy to identify cancer phenotypes.
New research from a team of scientists — and two specially trained dogs — have scientifically validated man’s best friend can “sniff out” prostate cancer.
A new clinically-validated saliva test has been shown to detect HPV-associated head and neck cancer with high accuracy.
As labs aim to minimize disruptions, they are increasingly investing in strategies focused on resilience and rapid recovery.
Flow cytometers are becoming increasingly compact and sophisticated, offering opportunities and challenges for routine clinical use.
New research suggests standard drug tests may miss low-level exposure in children—potentially sending them back into unsafe home environments—and suggests an alternative.
Rapid immunoassays have emerged as a valuable tool for providing quick information that can be crucial in life-threatening situations.
The test is approved to identify patients eligible for Hernexeos, an orally administered targeted treatment for HER2 (ERBB2)-mutant non-small cell lung cancer.
Labcorp and NOWDiagnostics have partnered to distribute free First to Know Syphilis Test kits to public health organizations nationwide.